
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CCR Translations |
v Integrins Lead the Way for Colorectal MetastasesAuthor's Affiliation: Department of Cancer Biology, University of Texas M. D. Anderson Cancer Center, Houston, Texas
Requests for reprints: Joseph H. McCarty, Department of Cancer Biology, University of Texas M. D. Anderson Cancer Center, Unit 173, 1515 Holcombe Boulevard, Houston, TX 77030. Phone: 713-792-0429; Fax: 713-792-8747; E-mail: jhmccarty{at}mdanderson.org.
Abstract
In this issue of Clinical Cancer Research, Conti et al. identify a crucial cell adhesion and signaling axis that promotes the proliferation, survival, and drug-resistant properties of metastatic colorectal cancer cells in the liver. The components of this pathway may be effective targets for therapeutically treating established metastatic tumors in patients with colorectal adenocarcinomas.
Key Article
v Integrin Ligation
Clin. Cancer Res. 2008 14: 6405-6413.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |